A condition where the body doesn't use insulin effectively and blood sugar runs high, strongly linked to weight and insulin resistance. Several GLP-1s were first approved for type 2 diabetes (Ozempic, Mounjaro) before their weight-management siblings (Wegovy, Zepbound) arrived. Whether a drug is labeled for diabetes or weight loss affects both your insurance coverage and which brand you're prescribed.
Related terms: A1c (HbA1c) · Prediabetes · Insulin resistance · Off-label prescribing